Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Stoke Therapeutics Inc..
Stoke Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Stoke Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Stoke Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Stoke Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Stoke Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Stoke Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Stoke Therapeutics Inc.- Key Facts
2.2 Stoke Therapeutics Inc.- Geographic Locations
2.3 Stoke Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Stoke Therapeutics Inc.- Business Divisions
2.5 Stoke Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Stoke Therapeutics Inc. Strategic Analysis Review
3.1 Stoke Therapeutics Inc.- Key Strategies
3.2 Stoke Therapeutics Inc.- Company Outlook Statement
3.3 Stoke Therapeutics Inc.- SWOT Analysis
3.3.1 Stoke Therapeutics Inc.- Key Strengths
3.3.2 Stoke Therapeutics Inc.- Key Weaknesses
3.3.3 Stoke Therapeutics Inc.- Potential Opportunities
3.3.4 Stoke Therapeutics Inc.- Potential Threats
3.4 Stoke Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Stoke Therapeutics Inc.- Business Overview
4.2 Stoke Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Stoke Therapeutics Inc.- Key Products
5.2 Stoke Therapeutics Inc.- Key Service Areas
5.3 Stoke Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Stoke Therapeutics Inc.- Company History
6.2 Stoke Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Stoke Therapeutics Inc.- Income Statements
7.2 Stoke Therapeutics Inc.- Balance Sheet
7.3 Stoke Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Stoke Therapeutics Inc.- Direct Competitors
8.2 Stoke Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Stoke Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Stoke Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!